Label2 (Label2)
Gabapentin
Product Images NDC 55695-017
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 55695-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Department Of State Health Services, Pharmacy Branch, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gabapentin-1 (Gabapentin 1)
The given text appears to be a medical equation used to estimate the glomerular filtration rate (GFR) of a patient using creatinine levels and relevant patient information. The output of this equation is the cLcr value, which is a measure of how well the kidneys are functioning. The specific equation takes into account the age and weight of the patient as well as their serum creatinine levels. The equation is as follows: cLcr = [140 - age (years) x weight (kg) / (72 x serum creatinine (mg/dL))]. It is important to note that this equation should only be used as an estimate and additional testing may be required to properly diagnose kidney function.*
Gabapentin-10 (Gabapentin 10)
Gabapentin-11 (Gabapentin 11)
Gabapentin-12 (Gabapentin 12)
Gabapentin-2 (Gabapentin 2)
Gabapentin-3 (Gabapentin 3)
Gabapentin-4 (Gabapentin 4)
Gabapentin-5 (Gabapentin 5)
Gabapentin-6 (Gabapentin 6)
The text describes a table or chart showing the Mean Pain Score for a study that appears to have involved a dose titration period followed by a fixed dose period. The table includes data for a placebo group and a group receiving 3600 mg/day of gabapentin. The data is separated by baseline and weeks, but without additional context it is difficult to provide more details.*
Gabapentin-7 (Gabapentin 7)
This is a chart displaying the mean pain score for different treatment periods of a medication, specifically Gabapentin at doses of 1800mg/day and 2400mg/day. The chart shows two periods: a 4-week fixed dose period and a titration period. The mean pain score during the fixed dose period is 0, while during the titration period it is not specified. The chart is divided into weeks, but no specific data is provided.*
Gabapentin-8 (Gabapentin 8)
Gabapentin-9 (Gabapentin 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
